The human CAN protein, a putative oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex protein that faces the cytoplasm ( Contributed by Gunter Blobel, November 12, 1993 ABSTRACT
CeU. Biol. 12, 1687-1697]. The CAN protein has been proposed to be a putative oncogene product associated with myeloid leukemogenesis. Its subcellular localization was not established. To confirm that the putative rat nucleoporin is indeed a homolog of the human CAN protein and to determine its subcellular localization, we expressed a 39-kDa internal segment of the 213,790-Da human CAN protein in Escherichia coli and raised monospecific antibodies, which reacted with the putative rat nucleoporin. Immunofluorescence microscopy of HeLa cells gave a punctate nuclear surface staining pattern characteristic of nucleoporins, and immunoelectron microscopy yielded specific decoration of the cytoplasmic side of the nuclear pore complex. This suggests that the protein is part of the short fibers that emanate from the cytoplasmic aspect of the nuclear pore complex. In agreement with previously proposed nomenclature for nucleoporins, we propose the alternative term nup214 (mcleoporin of 214 kDa) for the CAN protein.
Only 3 of the estimated 100 or more nuclear pore complex (NPC) proteins [collectively referred to as nucleoporins (1) ] have so far been molecularly characterized in vertebrate cells. These are p62 (2, 3), nuplS3 (4) , and nuplS5 (5) . By using monospecific antibodies, nuplS5 (5) and p62 (2) were found by immunoelectron microscopy to be located symmetrically on the nucleoplasmic and cytoplasmic aspects of the NPC. In contrast, nuplS3 was demonstrated to be located asymmetrically on only the nucleoplasmic side of the NPC (4), specifically on the terminal ring of the nuclear basket (6) . NuplS3 has been shown to contain four Cys-Cys-type zinc finger motifs and to bind to DNA in a zinc-dependent fashion (4) . It has been proposed to function in the three-dimensional organization of the chromatin (4) . The functions of p62 and nupl55 are unknown.
Two groups of vertebrate nucleoporins have so far been distinguished. One ofthem comprises about a dozen proteins, including p62 and nuplS3, that contain single N-acetylglucosamine (GlcNAc) residues attached to serine or threonine residues (refs. 7-14; for review, see ref. 15 ). As a consequence, these proteins react with wheat germ agglutinin (WGA) (1, 4, 7, (9) (10) (11) (12) (13) . The other group, comprising the bulk of the vertebrate nucleoporins and so far represented by nupl55, does not react with WGA (5). The WGA-reactive nups share repetitive sequence motifs with each other that are conserved across various species, including yeast (2) (3) (4) (16) (17) (18) (19) (20) (21) . These sequence motifs appear to be part of the epitope that is recognized by monoclonal antibodies (mAbs) (4, 7, 14, (16) (17) (18) (19) (20) (21) (22) , which may explain the observed polyspecificity of these mAbs. To molecularly characterize additional nucleoporins, we focused on one of the previously described WGA-and mAb 414-reactive proteins of the rat liver nuclear envelope that has an apparent molecular mass (based on mobility in SDS/PAGE) of =-225 kDa [previously estimated to have a molecular mass of -210 kDa (4) ]. In subcellular fractionation, p225 cofractionated with nuclear envelopes (4) and, like p62, nupl53, and nup155, was extractable by urea/EDTA (5) . Based on these criteria, p225 therefore appeared to be a strong candidate for an NPC protein. In preparation for cDNA cloning, we obtained partial amino acid sequence of internal peptides. Surprisingly, these amino acid sequences matched the cDNA-deduced amino acid sequence of the human CAN protein, a putative oncogene product of 213,790 Da that is associated with leukemogenesis (23) . Although not previously noted, the CAN protein sequence showed degenerate XFXFG pentapeptide motifs. This motif can be considered a nucleoporin signature since it is also found in p62 (2, 3, 16) , nuplS3 (4), and several yeast nucleoporins (17) (18) (19) (20) , clearly supporting the candidacy of CAN as a nucleoporin. However, although no data have been published on the cellular localization of the CAN protein, it was suggested to be a cytoplasmic protein (23) . To definitively sublocalize the CAN protein, we obtained antibodies that react monospecifically with the WGA-and mAb 414-reactive rat p225. In immunofluorescence ofHeLa cells these antibodies gave the punctate nuclear surface staining pattern characteristic for nucleoporins (1 detected with amido black. A strip of the membrane with the 225-kDa protein was cut out and digested with endoproteinase Lys C (Sigma), and the resulting fragments were separated by reversed-phase HPLC and subjected to automated Edman degradation (28) .
Five peaks ofthe HPLC profile were analyzed; one yielded a single sequence, one produced a double sequence, and three produced triple sequences. After protein homology searches with the single sequence in the GenBank data bases using the BLAST program (29) , a high similarity to the human protein CAN (23) was found. After this the mixed double and triple sequences could also be separated and all ofthem could be aligned to the sequence of CAN. Some of the sequences appeared in different HPLC peaks. Similarity was measured by using the similarity matrix of Henikoff and Henikoff (30 (3') were synthesized according to the published sequence of can (23) . Together with these primers, a human Agtll cDNA library (32) was used as template to synthesize the corresponding region ofthe can gene using the PCR. Amplification was conducted as described (5) except that the annealing temperature was increased to 480C. The reaction product of the expected size was gel purified, cut with EcoRI and HindIII (New England Biolabs), and subcloned into the pET21b plasmid (Novagen) in frame with six C-terminal histidine residues. The resulting plasmid was designated pET21b/p39. Sequencing of the insert was performed according to the dideoxy chain-termination method (33) using Sequenase 2.0 (United States Biochemical). The p39/6xHis fusion protein was expressed in the Escherichia coli cell line BL21(DE3) (Novagen). Cells were cultured in 50 ml of LB medium containing 50 ,ug of ampicillin (Sigma) per ml at 37TC until the OD60 reached 0.6-1.0. For induction, 1 mM isopropyl P-D-thiogalactoside (Boehringer Mannheim) and, 15 min later, 250 p.g of rifampicin (Boehringer Mannheim) per ml were added and the incubation was continued at 370C for 2.5 hr. The cells were harvested by centrifugation at 5000 x g for 5 min at 40C and the pellet was suspended in 12 ml of buffer A (5 mM imidazole/0.5 M NaCl/20 mM Tris-HCl, pH 7.9). Lysozyme (100 pg/ml) (United States Biochemical) and 0.05% Triton X-100 (Boehringer Mannheim) were also added. After incubation at 300C for 15 min the cells were disrupted by sonication. All of the following steps were carried out at 40C. After centrifugation for 20 min at 12,000 x g the pellet was suspended in 10 ml of 6 M urea in buffer A and the suspension was incubated for 1 hr. Insoluble cell debris was removed by centrifugation at 40,000 x g for 20 min. The supernatant was loaded on 2.5 ml of Ni2+-nitrilotriacetic acid-agarose (Qiagen, Chatsworth, CA), which was previously equilibrated with 7.5 ml of 6 M urea in buffer A. The column was washed with 25 ml of 6 M urea in buffer A and 15 ml of20 mM imidazole/0.5 M NaCl/20 mM Tris-HCl, pH 7.9/6 M urea, and the protein was eluted with 5 ml of 0.5 M imidazole/0.5 M NaCl/20 mM Tris HCl, pH 7.9/6 M urea (Novagen pET system manual). The protein concentration was determined according to Bradford (34) .
Anti-p39 Antibodies. (Rockland, Gilbertsville, PA). The serum was affinity purified using p39/6xHis bound to nitrocellulose (35) . For immunolocalization the affinity-purified antibodies were concentrated 5-fold in a Centricon microconcentrator (Amicon (4) . These mAbs decorate the NPC in immunoelectron microscopy. Fig. 1 shows the WGAreactive proteins separated by SDS/PAGE and stained with Coomassie blue (lane 2). Among them are the already molecularly characterized nucleoporins p62 (2, 3) and nupl53 (4) (lane 2, arrowhead). In preparation for the molecular cloning of a protein of -225 kDa (p225) (indicated by arrow in lane 2), p225 was subjected to proteolytic cleavage with endopro- Proc. Nadl. Acad. Sci. USA 91 (1994) teinase Lys C. The resulting peptides were separated by HPLC and some of them were subjected to amino acid sequencing. Surprisingly, a comparison of the obtained amino acid sequences with those in the data banks showed a high degree of similarity with the cDNA-deduced amino acid sequence of the human CAN protein throughout the entire length of the molecule (Fig. 2) . This suggested that the rat p225 is the homolog of the human CAN protein (23) . Although the subcellular localization ofthe human CAN protein has not been established, it has been suggested to be a cytoplasmic protein (23) , clearly at odds with it being a nucleoporin.
An analysis of the human CAN protein sequence (Fig. 3 ) revealed the presence of 11 redundant XFXFG motifs that are present in vertebrate p62 (2, 3, 16) and nuplS3 (4) as well as in various yeast nucleoporins (17) (18) (19) . This motif is likely to be part of the epitope reactive with mAb 414 (20) . In addition, there is one other tetrapeptide motif SVFG (see Fig.  3 ) and the repetitive motif FGG that have so far not been reported for other molecularly characterized nucleoporins. The tripeptide motif FGQ is part of the GGLFGQ motif in NUP100 and NUP116 (20, 21) . Especially the C-terminal a portion (amino acids 1213-2090) is unusually rich in serines (21%), threonines (12%), and prolines (9,%) (23) . Serines and threonines, which are located less than three residues from a proline, have been proposed to be potential sites for GlcNAc addition (8) . The amino acid sequence of CAN contains 32 potential phosphorylation sites (7 for protein kinase C, 24 for casein kinase II, and 1 for cAMP-dependent protein kinase).
Although the presence in the human CAN protein of the XFXFG motif was consistent with it being a nucleoporin, the low abundance of this motif (relative to that in other nucleoporins) as well as its considerable degeneracy made it far from certain that the human CAN protein is a nucleoporin. To definitively localize the human CAN protein it was therefore necessary to prepare monospecific antibodies. To obtain these we expressed a 39-kDa segment of the protein (residues 818-1175) in E. coli (Fig. 4A, lane 2) . This segment lacks the XFXFG motif that is part of the mAb 414-reactive epitope and the other repetitive motifs. Antibodies to this segment should therefore be monospecific for the human CAN protein. Indeed, the obtained antibodies reacted with the E. coli-expressed CAN protein segment (Fig. 4A, lane 3) and recognized a single 225-kDa protein in rat liver nuclear sĨ~~~~i .. envelopes (Fig. 4B, lane 1) . In addition, this antibody specifically recognized the mAb 414-reactive p225 polypeptide isolated from rat liver nuclear envelopes (data not shown).
These monosoedific antibodies were next used for indirect immunofluorescence microscopy of paraformaldehyde-fixed and Triton X-100-permeabilized HeLa cells grown on coverslips (Fig. 5) . Focusing on the nuclear rim (Fig. 5 Upper) or the nuclear surface (Fig. 5 Lower) revealed a punctate nuclear rim and surface staining pattern that is characteristic for nucleoporins (1) . Cytoplasmic staining was not detected.
To definitively localize p225 to the NPC we carried out immunoelectron microscopy. Frozen ultrathin sections of HeLa cells were incubated with the monospecific antibodies and then with 10-nm gold-conjugated secondary antibodies. The gold particles decorated NPCs (Fig. 6) . Most strikingly, they decorated only the cytoplasmic side of the NPC (Fig. 6) . Thus we conclude that the human CAN protein is a nucleoporin that is asymmetrically localized on the cytoplasmic side of the NPC.
DISCUSSION
The human CAN protein, a putative oncogene associated with myeloid leukemogenesis (23, 37) , has been shown here by immunoelectron microscopy to be a nucleoporin. Consistent with previous nomenclature, we therefore suggest the alternative term nup214 for this protein.
nup214 is only the fourth vertebrate nucleoporin that has been localized to the NPC (see Introduction). Its exclusive localization to the cytoplasmic side of the NPC suggests that. it may be part ofthe short "fibers" that extend 35-50 nm from the cytoplasmic aspect of the NPC (assuming that the protein composition of the cytoplasmic and the nucleoplasmic rings is identical). These fibers are the only macromolecular structures so far known to be asymmetrically associated with the NPC on its cytoplasmic side. nup214 and nuplS3 cofractionate quantitatively with nuclear envelopes. Thus, although nupl53 is located at the "extreme" nucleoplasmic end of the NPC and nup214 at its cytoplasmic perimeter, neither of them appears to be lost from the NPC during isolation of nuclear envelopes. This knowledge will be useful for further structural and functional analysis of components of the NPC in the context of isolated nuclear envelopes.
The function of nup214 remains to be determined. One possibility is that this protein serves as a docking site in the receptor-mediated import of substrates across the NPC (38, 39) . In fact, binding of gold-decorated nuclear import substrate to what could be such fibers has been reported previously (40) .
An understanding of the function of nup214 may also help in elucidating its presumed assc~iation with myeloid leuke- mogenesis. In Fig. 7 are summarized previously published data (23, 37) . This work showed that two distinct chromosome aberrations, a translocation and a fusion (both characteristic for myeloid leukemogenesis), yielded two chimeric proteins. Because each of these chimeric proteins shares a common C-terminal part derived from the C terminus of nup214 (Fig. 7) , nup214 (rather than the N-terminal DEK and SET proteins) was suggested to be the putative oncogene product (23, 37 
